相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment
Gianluca Gaidano et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG)
Paula Cramer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Prognostic factors and risk stratification in chronic lymphocytic leukemia
Sameer A. Parikh et al.
SEMINARS IN ONCOLOGY (2016)
The molecular pathogenesis of chronic lymphocytic leukaemia
Giulia Fabbri et al.
NATURE REVIEWS CANCER (2016)
Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Drak2 Does Not Regulate TGF-β Signaling in T Cells
Tarsha L. Harris et al.
PLOS ONE (2015)
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
Panagiotis Baliakas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
The DAPK family: a structure-function analysis
Ruth Shiloh et al.
APOPTOSIS (2014)
Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK
Sergey Krysov et al.
BLOOD (2014)
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2014)
Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
Lu Qian Wang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Apoptosis inducers in chronic lymphocytic leukemia
Christian Billard
ONCOTARGET (2014)
The MYB oncogene can suppress apoptosis in acute myeloid leukemia cells by transcriptional repression of DRAK2 expression
Ping Ye et al.
LEUKEMIA RESEARCH (2013)
DRAK2 Participates in a Negative Feedback Loop to Control TGF-β/Smads Signaling by Binding to Type I TGF-β Receptor
Kyung-Min Yang et al.
CELL REPORTS (2012)
Akt and mTOR in B cell activation and differentiation
Jose J. Limon et al.
FRONTIERS IN IMMUNOLOGY (2012)
Protein Kinase D Orchestrates the Activation of DRAK2 in Response to TCR-Induced Ca2+ Influx and Mitochondrial Reactive Oxygen Generation
Ryan H. Newton et al.
JOURNAL OF IMMUNOLOGY (2011)
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
Ulf Klein et al.
CANCER CELL (2010)
NF-kappa B as a therapeutic target in chronic lymphocytic leukemia
Monica Lopez-Guerra et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
From pathogenesis to treatment of chronic lymphocytic leukaemia
Thorsten Zenz et al.
NATURE REVIEWS CANCER (2010)
A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic Leukemia
Sandra Loeder et al.
CANCER RESEARCH (2009)
A role for DRAK2 in the germinal center reaction and the antibody response
Ahmed Al-Qahtani et al.
AUTOIMMUNITY (2008)
Drak2 Overexpression Results in Increased β-Cell Apoptosis After Free Fatty Acid Stimulation
Jianning Mao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Enhanced T Cell Apoptosis within Drak2-Deficient Mice Promotes Resistance to Autoimmunity
Stephanie J. Ramos et al.
JOURNAL OF IMMUNOLOGY (2008)
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
Aparna Raval et al.
CELL (2007)
Nuclear localization of the serine/threonine kinase DRAK2 is involved in UV-induced apoptosis
H Kuwahara et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
A Petlickovski et al.
BLOOD (2005)
Mechanisms of disease: Chronic lymphocytic leukemia
N Chiorazzi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity
MA McGargill et al.
IMMUNITY (2004)
Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2002)
VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
A Kröber et al.
BLOOD (2002)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
